Clinical Edge Journal Scan

Fatigue prevalent and persistent even in early RA


 

Key clinical point: Fatigue was prevalent and persistent in patients with early rheumatoid arthritis (RA) with female gender, poor mental health, pain, and some functional abilities associated with greater fatigue.

Major finding: The age- and sex-standardized prevalence of fatigue and severe fatigue was 44% (95% CI 39%-50%) and 19% (95% CI 15%-23%), respectively, with little change observed over 3 years (ß 0.13; 95% CI 0.23 to 0.02). Female gender, worse pain, mental health, and functional ability were significantly associated with greater fatigue ( P ≤ .05).

Study details: This was a multicenter cohort study involving 729 patients with RA with symptom duration of <2 years.

Disclosures: This work was funded by the Versus Arthritis Pain Centre. DF McWilliams and DA Walsh reported receiving funding and consultancy fees from various sources.

Source: Ifesemen OS et al. Rheumatology (Oxford). 2021;keab861 (Dec 27). Doi: 10.1093/rheumatology/keab947 .

Recommended Reading

Doctor-patient relation can help improve treatment adherence in RA
MDedge Rheumatology
Inflammatory cytokines positively correlate with coinhibitory checkpoint molecules in RA
MDedge Rheumatology
No higher risk for surgical site infection following TKA in RA vs. osteoarthritis
MDedge Rheumatology
Flaxseed shows promise as adjuvant therapy in RA
MDedge Rheumatology
Herpes zoster events are common in tofacitinib-treated RA patients but are clinically manageable
MDedge Rheumatology
Circulating biomarkers may aid in screening for cardiac alterations in RA
MDedge Rheumatology
Clinical Edge Journal Scan Commentary: RA January 2022
MDedge Rheumatology
Proactive infliximab monitoring found best for sustaining control of inflammatory diseases
MDedge Rheumatology
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
MDedge Rheumatology
Immunological response after SARS-CoV-2 vaccine in rituximab-treated RA patients
MDedge Rheumatology